| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 2 | +22.5K | 17.6% | $8.01 | +$180K |
| Sells | 3 | -105K | 82.4% | $9.56 | -$1.01M |
| Net | -1 | -82.8K | -64.8% | -$827K |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 10%+ Owner | $60.5M | Jan 24, 2024 | ||
| James Topper | Director, 10%+ Owner | $53.4M | May 23, 2024 | ||
| Takeda Pharmaceutical Co Ltd | 10%+ Owner | $30.4M | Jan 24, 2024 | ||
| David A. Socks | Director | $11.2M | May 23, 2024 | ||
| Azmi Nabulsi | Chief Operating Officer | $9.51M | -$189K | -1.95% | Jan 21, 2025 |
| Terrie Curran | President and Chief Executive, Director | $2.4M | -$676K | -22% | Jan 21, 2025 |
| Molly Henderson | CFO and CBO | $1.77M | -$143K | -7.45% | Jan 21, 2025 |
| Asit Parikh | Director | $613K | +$81.2K | +15.3% | Dec 13, 2024 |
| Frank Karbe | Director | $452K | +$99.1K | +28.1% | Dec 13, 2024 |
| Michael F. Cola | Director | $267K | May 23, 2024 | ||
| Mark Stenhouse | Director | $178K | May 23, 2024 | ||
| Heidi Fields | Director | $178K | May 23, 2024 | ||
| Anthony J. Guzzo | VP, Chief Accounting Officer | $71.8K | Jan 19, 2022 | ||
| Tadataka Yamada | Director | May 21, 2021 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|